The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5586-5595

  Giuliano, Michela ^a   Lauricella, Marianna ^a   Calvaruso, Giuseppe ^a   Carabillò, Maria ^a   Emanuele, Sonia ^a   Vento, Renza ^a   Tesoriere, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BUTYRIC ACID; CASPASE 3; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMIN B; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETINOBLASTOMA;

EID: 0033230594     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cummings, J. H. Short chain fatty acids in the human colon. Gut, 28: 3-13, 1981.
2. Barnard, J. A., and Warwick, G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ., 4: 495-501, 1993.
3. Hague, A., Manning, A. M., Hanlon, K. A., Huschtscha, L. I., Hart, D., and Paraskeva, C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55: 498-505, 1993.
4. Medina, V., Edmonds, B., Young, G. P., James, R., Appleton, S., and Zalewski, P. D. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res., 57: 3697-3707, 1997.
5. Janson, W., Brandner, G., and Siegel, J. Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis. Oncogene, 15: 1395-1406, 1997.
6. Bonnotte, B., Favre, N., Reveneau, S., Micheau, O., Droin, N., Garrido, C., Fontana, A., Chauffert, B., Solary, E., and Martin, F. Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death Differ., 5: 480-487, 1998.
7. Arts, J., Lansink, M., Grimbergen, J., Toet, K. H., and Kooistra, T. Stimulation of tissue type plasminogen activator gene expression by sodium butyrate and TSA in human endothelial cells involves histone acetylation. Biochem. J., 310: 171-176, 1995.
8. Lee, E. Y-H. P., Bookstein, R., Young, L-J., Lin, C-J., Rosenfeld, M. G., and Lee, W-H. Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc. Natl. Acad. Sci. USA, 85: 6017-6021, 1988.
9. Linardopoulo, S., Gonos, E. S., and Spandidos, D. A. Abnormalities of retinoblastoma gene structure in human lung tumors. Cancer Lett., 71: 67-74, 1993.
10. Mittnacht, S. Control of pRB phosphorylation. Curr. Opin. Genet. Dev., 8: 21-27, 1998.
11. Herwig, S., and Strauss, M. The retinoblastoma protein: a master regulator of cell cycle differentiation and apoptosis. Eur. J. Biochem., 246: 581-601, 1997.
12. Kasten, M. M., and Giordano, A. pRb and the Cdks in apoptosis and the cell cycle. Cell Death Differ., 5: 132-140, 1998.
13. Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P. A. TA., Fung, Y. K., and Israel, M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J., 14: 461-472, 1995.
14. Hsieh, J-K., Fredersdorf, S., Kouzarides, T., Martin, K., and Lu, X. E2F1-induced apoptosis required DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev., 11: 1840-1852, 1997.
15. Kyritsis, T., Joseph, G., and Chader, G. J. Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures. J. Natl. Cancer Inst., 73: 649-654, 1984.
16. Conway, R. M., Madigan. M. C., Penfold, P. L., and Billson, F. A. Induction of apoptosis by sodium butyrate in the human Y-79 retinoblastoma cell line. Oncol. Res., 7: 289-297, 1995.
17. Lauricella, M., Giuliano, M., Emanuele, S., Vento, R., and Tesoriere, G. Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells. Tumour Biol., 19: 356-363, 1998.
18. Giuliano, M., Lauricella, M., Vassallo, E., Carabillò, M., Vento, R., and Tesoriere, G. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors. Invest. Ophthalmol. Visual Sci., 39: 1300-1311, 1998.
19. Di Felice, V., Lauricella, M., Giuliano, M., Emanuele, S., Vento, R., and Tesoriere, G. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. Int. J. Oncol., 13: 225-232, 1998.
20. 2-ceramide. Mol. Cell. Biochem., 185: 7-15, 1998.
21. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application and cytotoxicity assay. J. Immunol. Methods, 65: 55-63, 1983.
22. Giuliano, M., Vento, R., Lauricella, M., Calvaruso, G., Carabillò, M., and Tesoriere, G. Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells. Eur. J. Biochem., 236: 523-532, 1996.
23. Carollo, M., Parente, L., and D'Alessandro, N. Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by Lipocortin I. Oncol. Res., 10: 245-254, 1998.
24. Roff, M., Thompson, J., Rodriguez, M. S., Jacque J-M., Baleux, F., Arenzana-Seisdedos, F., and Hay, R. T. Role of I κBα ubiquitination in signal-induced activation of NF-κB in vivo. J. Biol. Chem., 271: 7844-7849, 1996.
25. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T., Jones, D. P., and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (Washington DC), 275: 1129-1132, 1997.
26. Beyette, J., Mason, G. G. F., Murray, R. Z., Cohen, G. M., and Rivett, A. J. Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes. Biochem. J., 332: 315-320, 1998.
27. Rivett, A. J., Savory, P. J., and Djaballah, H. Multicatalytic endopeptidase complex: proteasome. Methods Enzymol., 244: 331-350, 1994.
28. Wilson, M. R. Apoptosis: unmasking the executioner. Cell Death Differ., 5: 646-652, 1998.
29. Cuvillier, O., Rosenthal, D. S., Smulson, M. E., and Spiegel, S. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem., 273: 2910-2916, 1998.
30. Hilt, W., and Wolf, D. H. Proteasomes: destruction as a programme. Trends Biochem. Sci., 21: 96-101, 1996.
31. Scheffner, M., Huibregtse, J., and Howley, P. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. USA, 91: 8797-8801, 1994.
32. Ciechanover, A., Di Giuseppe, J., Bercovich, B., Orian, A., Richter, J., Schwanz, A., and Brodeur, G. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA. 88: 139-143, 1991.
33. Bouchard, C., Staller, P., and Eilers, M. Control of cell proliferation by Myc. Trends Cell Biol., 8: 202-206, 1998.
34. Lee, W. H., Murphree, A. L., and Benedict, W. F. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature (Lond.), 309: 458-460, 1984.
35. Xiao, H., Hasegawa, T., Miyaishi, O., Ohkusu, K., and Isobe, K. Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21/WAFI in p53-independent manner. Biochem. Biophys. Res. Commun., 237: 457-460, 1997.
36. Campanero, M. R., and Flemington, E. K. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA, 94: 2221-2226, 1997.
37. Baeuerle, P. A., and Baltimore, D. IκB: a specific inhibitor of the NF-κB transcription factor. Science (Washington DC), 242: 540-546, 1988.
38. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
39. Schendel, S. L., Montal, M., and Reed, J. C. Bcl-2 family proteins as ion-channels. Cell Death Differ., 5: 372-380, 1998.
40. Litvak, D. A., Evers, B. M., Hwang, K. O., Hellmich, M. R., Ko, T. C., and Townsend, C. M., Jr. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21/Waf1 and p27Kip I. Surgery, 124: 161-170, 1998.
41. 1 during growth arrest. Exp. Cell Res., 241: 324-331, 1998.
42. Joensuu, T., and Mester, J. Inhibition of cell cycle progression by sodium butyrate in normal rat kidney fibroblasts is altered by expression of the adenovirus 5 early 1A gene. Biosci. Rep., 14: 291-300, 1994.
43. Pagano, M., Tam, S. W., Theodoras, A. M., Romero-Beer, P., Del Sal, G., Chau, V., Yew, R., Draetta, G., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
44. 1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J., 14: 303-312, 1995.
45. Alkalay, K., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A., and Ben-Neriah, Y. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA, 92: 10599-10603, 1995.
46. Kalderon, D. Protein degradation: de-ubiquitinate to decide your fate. Curr. Biol., 6: 662-665, 1996.
47. Zhang, Z., Clawson, A., Realini, C., Jensen, C. C., Knowlton, J. R. Hill, C. P., and Rechsteiner, M. Identification of an activation region in the proteasome activator REGα. Proc. Natl. Acad. Sci. USA, 95: 2807-2811, 1998.
48. Ruiz de Mena, I., Mahillo, E., Arribas, J., and Castano, J. G. Kinetic mechanism of activation by cardiolipin (diphosphatidylglycerol) of the rat liver multicatalytic proteinase. Biochem. J., 296: 93-97, 1993.
49. Yamada, S., Yamada, J., Sato, K., Tokumoto, T., Yasutomi, M., and Ishikawa, K. Irreversible potent activation and reversible inhibition of trypsin-like activity of 20S proteasome purified from Xenopus oocytes by fatty acids. Zool. Sci., 15: 43-49, 1998.
50. Lee, D. H., and Goldberg, A. L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol., 8: 397-403, 1998.
51. 1waf1/cip1. Genes Dev., 8: 2817-2930, 1994.
52. Han, J. W., Dionne, C. A., Kedersha, N. L., and Goldmacher, V. S. p53 status affects the rate of the onset but rot the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc. Cancer Res., 57: 176-182, 1997.
53. Van Antwerp, D. J., Martin, S. J., Verma, I. M., and Green, D. R. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol., 8: 107-111, 1998.
54. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science (Washington DC), 281: 1680-1683, 1998.
55. Delic, J., Masdehors, P., Omura, S., Cosset, J. M., Dumont, J., Binet, J. L., and Magdelenat, H. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-α-initiated apoptosis. Br. J. Cancer, 77: 1103-1107, 1998.
56. Lopez, U. G., Erhardt, P., Yao, R., and Cooper, G. M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem., 272: 12893-12896, 1997.
57. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J., and Tan, T. H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J. Biol. Chem., 271: 31929-31936, 1996.
58. Wu, X. W., and Levine, A. J. p53 and E2F1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
59. Andrews, P. A., and Howell, S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells, 2: 35-43, 1990.
60. Miller, A. A., Kurschel, E., Osieka, R., and Schmidt, C. G. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur. J. Cancer Clin. Oncol., 23: 1283-1287, 1987.
61. Grimm, L. M., Goldberg, A. L., Poirier, G. G., Schwartz, M. L., and Osborne, B. A. Proteasomes play an essential role in thymocyte apoptosis. EMBO J., 15: 3835-3844, 1996.